An experimental flu vaccine consisting of billions of tiny spherical sacs that carry infection-fighting proteins throughout the body has proven effective in preclinical studies. The vaccine has the potential to improve the effectiveness of seasonal flu vaccines, accelerate vaccine production timelines and increase vaccine supplies because of its small dosage.